Delivery Order SPE2DB20D1100-SPE2DB23FC3G7
Award Date 6/28/23
Potential Completion Date 7/20/23
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,242 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin used for medical treatments. Performance will take place in Conshohocken, Pennsylvania over a three-week period concluding in late August 2023. The firm fixed price order was issued under an unspecified multiple award contract vehicle and does not include any small business set-aside designations. Amerisourcebergen will supply the botulinum toxin...
- The Defense Logistics Agency awarded a $22,018 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from September 29th through October 23rd, 2023, this order is in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified. The award utilizes an existing DLA medical product contract vehicle to procure this botulinum toxin, supporting the...
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The order is to be performed in Conshohocken, Pennsylvania from August 18th through September 11th, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will supply the botulinum toxin type A injection to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $855 to Amerisourcebergen Drug Corporation to supply 50 vials of Xeomin. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin to a facility in Conshohocken, Pennsylvania under a September to October 2023 period of performance. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to support...
- The Defense Logistics Agency awarded a $157,272 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562185243 units of Xeomin 100 unit vials. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the botulinum toxin type A vials from its Conshohocken, Pennsylvania facility to support DLA requirements. No subcontractors or set aside designations were identified. The one month period of performance from September 14 to October 5, 2023 aligns with DLA's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $786 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The contract has a period of performance from June 23 to July 17, 2023, with all work to be conducted in Conshohocken, Pennsylvania. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for a botulinum toxin appears to support routine medical needs within the DLA's supply chain...
- The Defense Logistics Agency awarded a $40,462 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The contract has a period of performance from August 28, 2023 through September 19, 2023, with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will deliver the botulinum toxin under this contract as the prime contractor, with oversight from the Defense Logistics Agency. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $9,288.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562199420 units of Xeomin 100 unit vials. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin type A injection to its place of performance in Conshohocken, Pennsylvania by October 6, 2023 to support Department of Defense requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a $4,718 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 vials of Xeomin, a botulinum toxin used for medical treatments. The contract has a period of performance from September 12, 2023 through October 3, 2023, with all items to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,718.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 1, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the botulinum toxin appears to support routine medical needs. No subcontractors or set-aside designations were indicated.
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FC3G7Delivery Order
The Defense Logistics Agency awarded a $23,590.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin to its place of performance in Conshohocken, Pennsylvania by July 20th, 2023 to fulfill DLA's requirements. No subcontractors or set aside designations were indicated. This contract supports DLA's medical supply procurement programs and will provide the U.S. military with needed pharmaceutical products managed by the agency.
Generated 12/23/23, 2:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 6/28/23 |